Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma: a Randomized Controlled Clinical Trial

NCT01128699 is registered in ClinicalTrials.gov with Vanak Eye Surgery Center as lead sponsor.

NCT NCT01128699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma: a Randomized Controlled Clinical Trial
Lead sponsor
Vanak Eye Surgery Center
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2010
Completion date
July 31, 2011
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory glaucoma